Literature DB >> 25530747

Dynamic Optimal Strategy for Monitoring Disease Recurrence.

Hong Li1, Constantine Gatsonis2.   

Abstract

Surveillance to detect cancer recurrence is an important part of care for cancer survivors. In this paper we discuss the design of optimal strategies for early detection of disease recurrence based on each patient's distinct biomarker trajectory and periodically updated risk estimated in the setting of a prospective cohort study. We adopt a latent class joint model which considers a longitudinal biomarker process and an event process jointly, to address heterogeneity of patients and disease, to discover distinct biomarker trajectory patterns, to classify patients into different risk groups, and to predict the risk of disease recurrence. The model is used to develop a monitoring strategy that dynamically modifies the monitoring intervals according to patients' current risk derived from periodically updated biomarker measurements and other indicators of disease spread. The optimal biomarker assessment time is derived using a utility function. We develop an algorithm to apply the proposed strategy to monitoring of new patients after initial treatment. We illustrate the models and the derivation of the optimal strategy using simulated data from monitoring prostate cancer recurrence over a 5-year period.

Entities:  

Keywords:  Cancer recurrence surveillance; Keywords Biomarker trajectory; Latent class model; Optimal strategy; Time-dependent hazard

Year:  2012        PMID: 25530747      PMCID: PMC4269482          DOI: 10.1007/s11425-012-4475-y

Source DB:  PubMed          Journal:  Sci China Math        ISSN: 1869-1862            Impact factor:   1.331


  40 in total

Review 1.  Surveillance after colorectal cancer resection.

Authors:  J M Berman; R J Cheung; D S Weinberg
Journal:  Lancet       Date:  2000-01-29       Impact factor: 79.321

2.  ROC methodology within a monitoring framework.

Authors:  Corette B Parker; Elizabeth R DeLong
Journal:  Stat Med       Date:  2003-11-30       Impact factor: 2.373

3.  Colorectal cancer follow-up: a reassessment of empirical evidence on effectiveness.

Authors:  J Kievit
Journal:  Eur J Surg Oncol       Date:  2000-06       Impact factor: 4.424

4.  Individualized predictions of disease progression following radiation therapy for prostate cancer.

Authors:  Jeremy M G Taylor; Menggang Yu; Howard M Sandler
Journal:  J Clin Oncol       Date:  2005-02-01       Impact factor: 44.544

5.  Joint analysis of multiple longitudinal outcomes: application of a latent class model.

Authors:  Hein Putter; Tineke Vos; Hanneke de Haes; Hans van Houwelingen
Journal:  Stat Med       Date:  2008-12-20       Impact factor: 2.373

6.  Effectiveness of intensive follow-up after response in patients with small cell lung cancer.

Authors:  Tomohide Sugiyama; Takashi Hirose; Takamichi Hosaka; Sojiro Kusumoto; Masanao Nakashima; Toshimitsu Yamaoka; Kentaro Okuda; Tohru Ohmori; Mitsuru Adachi
Journal:  Lung Cancer       Date:  2007-09-27       Impact factor: 5.705

7.  Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach.

Authors:  Cécile Proust-Lima; Jeremy M G Taylor
Journal:  Biostatistics       Date:  2009-04-15       Impact factor: 5.899

8.  Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma.

Authors:  Osnat Bairey; Dorit Blickstein; Pinhas Stark; Miron Prokocimer; Hila Magen Nativ; Ilia Kirgner; Mati Shaklai
Journal:  Leuk Lymphoma       Date:  2003-10

Review 9.  Ongoing care of patients after primary treatment for their cancer.

Authors:  Herman Kattlove; Rodger J Winn
Journal:  CA Cancer J Clin       Date:  2003 May-Jun       Impact factor: 508.702

10.  Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy.

Authors:  M K Tuxen; G Sölétormos; P Dombernowsky
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640

View more
  4 in total

1.  A Value-of-Information Framework for Personalizing the Timing of Surveillance Testing.

Authors:  Aasthaa Bansal; Patrick J Heagerty; Lurdes Y T Inoue; David L Veenstra; Charles J Wolock; Anirban Basu
Journal:  Med Decis Making       Date:  2021-11-07       Impact factor: 2.583

Review 2.  Joint Analyses of Longitudinal and Time-to-Event Data in Research on Aging: Implications for Predicting Health and Survival.

Authors:  Konstantin G Arbeev; Igor Akushevich; Alexander M Kulminski; Svetlana V Ukraintseva; Anatoliy I Yashin
Journal:  Front Public Health       Date:  2014-11-06

3.  The value of time-dependent risk predictions in a screening context - a comprehensive simulation analysis validated on German cancer registry data.

Authors:  Vinzenz Voelkel; Teresa Draeger; Sietse van Mossel; Sabine Siesling; Hendrik Koffijberg
Journal:  BMC Med Res Methodol       Date:  2022-09-10       Impact factor: 4.612

Review 4.  Joint models for dynamic prediction in localised prostate cancer: a literature review.

Authors:  Harry Parr; Emma Hall; Nuria Porta
Journal:  BMC Med Res Methodol       Date:  2022-09-19       Impact factor: 4.612

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.